SPRY4 and urinary bladder carcinoma: Screening for novel urinary EV lncRNA candidates for bladder cancer diagnosis identified MALAT1, PCAT-1, and SPRY4-IT1 differential expression to be of high diagnostic value in a training set consisting of 208 urine samples, which was subsequently confirmed in a validation set (160 urine samples) [78].